T

Tsubota Laboratory Inc
TSE:4890

Watchlist Manager
Tsubota Laboratory Inc
TSE:4890
Watchlist
Price: 316 JPY 0.32% Market Closed
Market Cap: ¥8.1B

Operating Margin

-19%
Current
Improving
by 34.7%
vs 3-y average of -53.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-19%
=
Operating Income
¥-185.2m
/
Revenue
¥973.2m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-19%
=
Operating Income
¥-185.2m
/
Revenue
¥973.2m

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Tsubota Laboratory Inc
TSE:4890
8.2B JPY
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

Lower than 96% of companies in Japan
Percentile
4th
Based on 6 730 companies
4th percentile
-19%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Tsubota Laboratory Inc
Glance View

Market Cap
8.1B JPY
Industry
Pharmaceuticals

Tsubota Laboratory Inc is a JP-based company operating in Pharmaceuticals industry. The company is headquartered in Shinjuku, Tokyo-To and currently employs 9 full-time employees. The company went IPO on 2022-06-23. Tsubota Laboratory Inc is a Japan-based company mainly engaged in the research and development of new treatments for myopia, dry eye, and presbyopia. The firm operates with a B2B business model. The model generates revenue from lump-sum payments under joint research and development agreements and licensing agreements with partner companies, milestone payments, and royalties under post-commercialization (post-launch) loyalty agreements and creates new value by investing the profits in the new research. The firm is also engaged in the research and development of products for adults that treat depression and dementia, improve sleep and increase concentration.

Intrinsic Value
142.26 JPY
Overvaluation 55%
Intrinsic Value
Price
T
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-19%
=
Operating Income
¥-185.2m
/
Revenue
¥973.2m
What is Tsubota Laboratory Inc's current Operating Margin?

The current Operating Margin for Tsubota Laboratory Inc is -19%, which is above its 3-year median of -53.8%.

How has Operating Margin changed over time?

Over the last 3 years, Tsubota Laboratory Inc’s Operating Margin has decreased from 21.8% to -19%. During this period, it reached a low of -446.6% on Dec 31, 2023 and a high of 30.8% on Dec 31, 2024.

Back to Top